The global Companion Diagnostics for Oncology market is projected to reach $6.18 billion by 2028, expanding at a compound annual growth rate (CAGR) of 18.65% from 2021 to 2028. This growth is driven by various macroeconomic and microeconomic factors, including the rising number of cancer tests, which significantly contributes to the increasing demand for companion diagnostics in oncology.
The latest research report by Evolve Business Intelligence explores the various factors influencing the global market. It includes an analysis of the current market size, forecasts for key segments and regions, and the driving forces behind market growth. The report examines the potential impacts of key trends on business strategies and provides a SWOT analysis of critical sectors for each major competitor and customer group. This valuable data highlights the conglomerates likely to impact the industry, crucial for any company planning to invest strategically over the next five years. These insights complement our initial quantitative study, aiding in new investments and strategic planning to mitigate threats in existing sectors.
Segments covered
By Technology (Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Immunohistochemistry (IHC), In situ hybridization (ISH), Fluorescence in situ hybridization (FISH), Others)
By Disease Type (Breast Cancer, Non-Small Cell Lung Cancer, Colorectal Cancer, Leukemia, Melanoma, Others)
By End-user (Hospital, Pathology/Diagnostic Laboratory, Academic Medical Center, Others)
Key players
Agilent Technologies, Inc
QIAGEN N.V.
Thermo Fisher Scientific, Inc.
Hoffmann-La Roche Ltd.
ARUP Laboratories
Abbott
Myriad Genetics, Inc.
bioMérieux SA
Illumina, Inc.
Invivoscribe, Inc.
- Chapter 1. Executive Summary
- Chapter 2. Scope of The Study
- 2.1. Market Definition
- 2.2. Scope of The Study
- 2.2.1. Objectives of Report
- Chapter 3. Evolve BI Methodology
- Chapter 4. Market Insights and Trends
- 4.1. Supply/ Value Chain Analysis
- 4.2. Porter’s Five Forces Analysis
- 4.2.1. Threat of New Entrants
- 4.2.2. Bargaining Power of Buyers
- 4.2.3. Bargaining Power of Suppliers
- 4.2.4. Threat of Substitutes
- 4.2.5. Industry Rivalry
- 4.3. Impact of COVID-19 on Companion Diagnostics for Oncology Market
- 4.3.1. Impact on Market Size
- 4.3.2. End User Trend, Preferences and Budget Impact
- 4.3.3. Regulatory Framework/Government Policies
- 4.3.4. Key Players Strategy to Tackle Negative Impact
- 4.3.5. Opportunity Window
- Chapter 5. Market Dynamics
- 5.1. Introduction
- 5.2. DRO Analysis
- 5.2.1. Drivers
- 5.2.2. Restraints
- 5.2.3. Opportunities
- Chapter 6. Global Companion Diagnostics for Oncology Market, By Technology
- 6.1. Introduction
- 6.2. Polymerase Chain Reaction (PCR)
- 6.3. Next-Generation Sequencing (NGS)
- 6.3. Immunohistochemistry (IHC)
- 6.4. In situ hybridization (ISH)
- 6.5. Fluorescence in situ hybridization (FISH)
- 6.6. Others
- Chapter 7. Global Companion Diagnostics for Oncology Market, By Disease Type
- 7.1. Introduction
- 7.2. Breast Cancer
- 7.3. Non-Small Cell Lung Cancer
- 7.4. Colorectal Cancer
- 7.5. Leukemia
- 7.6. Melanoma
- 7.7. Others
- Chapter 8. Global Companion Diagnostics for Oncology Market, By End-user
- 8.1. Introduction
- 8.2. Hospital
- 8.3. Pathology/Diagnostic Laboratory
- 8.4. Academic Medical Center
- 8.5. Others
- Chapter 9. Global Companion Diagnostics for Oncology Market, By Region
- 9.1. Introduction
- 9.2. North America
- 9.2.1. Introduction
- 9.2.2. Driving Factors, Opportunity Analyzed and Key Trends
- 9.2.3. Market Size and Forecast, By Country, 2020 - 2028
- 9.2.4. Market Size and Forecast, By Technology, 2020 - 2028
- 9.2.5. Market Size and Forecast, By Disease Type, 2020 – 2028
- 9.2.6. Market Size and Forecast, By End-user, 2020 – 2028
- 9.2.7. US
- 9.2.7.1. Introduction
- 9.2.7.2. Driving Factors, Opportunity Analyzed and Key Trends
- 9.2.7.3. Market Size and Forecast, By Technology, 2020 - 2028
- 9.2.7.4. Market Size and Forecast, By Disease Type, 2020 – 2028
- 9.2.7.5. Market Size and Forecast, By End-user, 2020 - 2028
- 9.2.8. Canada
- 9.2.8.1. Introduction
- 9.2.8.2. Driving Factors, Opportunity Analyzed and Key Trends
- 9.2.8.4. Market Size and Forecast, By Technology, 2020 - 2028
- 9.2.8.5. Market Size and Forecast, By Disease Type, 2020 – 2028
- 9.2.8.6. Market Size and Forecast, By End-user, 2020 - 2028
- 9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Driving Factors, Opportunity Analyzed and Key Trends
- 9.3.3. Market Size and Forecast, By Country, 2020 - 2028
- 9.3.4. Market Size and Forecast, By Technology, 2020 - 2028
- 9.3.5. Market Size and Forecast, By Disease Type, 2020 – 2028
- 9.3.6. Market Size and Forecast, By End-user, 2020 – 2028
- 9.3.7. Germany
- 9.3.7.1. Introduction
- 9.3.7.2. Driving Factors, Opportunity Analyzed and Key Trends
- 9.3.7.3. Market Size and Forecast, By Technology, 2020 - 2028
- 9.3.7.4. Market Size and Forecast, By Disease Type, 2020 – 2028
- 9.3.7.5. Market Size and Forecast, By End-user, 2020 - 2028
- 9.3.8. France
- 9.3.8.1. Introduction
- 9.3.8.2. Driving Factors, Opportunity Analyzed and Key Trends
- 9.3.8.3. Market Size and Forecast, By Technology, 2020 - 2028
- 9.3.8.4. Market Size and Forecast, By Disease Type, 2020 – 2028
- 9.3.8.5. Market Size and Forecast, By End-user, 2020 - 2028
- 9.3.9. UK
- 9.3.9.1. Introduction
- 9.3.9.2. Driving Factors, Opportunity Analyzed and Key Trends
- 9.3.9.3. Market Size and Forecast, By Technology, 2020 - 2028
- 9.3.9.4. Market Size and Forecast, By Disease Type, 2020 – 2028
- 9.3.9.5. Market Size and Forecast, By End-user, 2020 - 2028
- 9.3.10. Italy
- 9.3.10.1. Introduction
- 9.3.10.2. Driving Factors, Opportunity Analyzed and Key Trends
- 9.3.10.3. Market Size and Forecast, By Technology, 2020 - 2028
- 9.3.10.4. Market Size and Forecast, By Disease Type, 2020 – 2028
- 9.3.10.5. Market Size and Forecast, By End-user, 2020 - 2028
- 9.3.11. Rest of Europe
- 9.3.11.1. Introduction
- 9.3.11.2. Driving Factors, Opportunity Analyzed and Key Trends
- 9.3.11.3. Market Size and Forecast, By Technology, 2020 - 2028
- 9.3.11.4. Market Size and Forecast, By Disease Type, 2020 – 2028
- 9.3.11.5. Market Size and Forecast, By End-user, 2020 - 2028
- 9.4. Asia-Pacific
- 9.4.1. Introduction
- 9.4.2. Driving Factors, Opportunity Analyzed and Key Trends
- 9.4.3. Market Size and Forecast, By Country, 2020 - 2028
- 9.4.4. Market Size and Forecast, By Technology, 2020 - 2028
- 9.4.5. Market Size and Forecast, By Disease Type, 2020 – 2028
- 9.4.7. Market Size and Forecast, By End-user, 2020 - 2028
- 9.4.8. China
- 9.4.8.1. Introduction
- 9.4.8.2. Driving Factors, Opportunity Analyzed and Key Trends
- 9.4.8.3. Market Size and Forecast, By Technology, 2020 - 2028
- 9.4.8.4. Market Size and Forecast, By Disease Type, 2020 – 2028
- 9.4.8.5. Market Size and Forecast, By End-user, 2020 - 2028
- 9.4.9. India
- 9.4.9.1. Introduction
- 9.4.9.2. Driving Factors, Opportunity Analyzed and Key Trends
- 9.4.9.3. Market Size and Forecast, By Technology, 2020 - 2028
- 9.4.9.4. Market Size and Forecast, By Disease Type, 2020 – 2028
- 9.4.9.5. Market Size and Forecast, By End-user, 2020 - 2028
- 9.4.10. Japan
- 9.4.10.1. Introduction
- 9.4.10.2. Driving Factors, Opportunity Analyzed and Key Trends
- 9.4.10.3. Market Size and Forecast, By Technology, 2020 - 2028
- 9.4.10.4. Market Size and Forecast, By Disease Type, 2020 – 2028
- 9.4.10.5. Market Size and Forecast, By End-user, 2020 - 2028
- 9.4.11. South Korea
- 9.4.11.1. Introduction
- 9.4.11.2. Driving Factors, Opportunity Analyzed and Key Trends
- 9.4.11.3. Market Size and Forecast, By Technology, 2020 - 2028
- 9.4.11.4. Market Size and Forecast, By Disease Type, 2020 – 2028
- 9.4.11.5. Market Size and Forecast, By End-user, 2020 - 2028
- 9.4.12. Rest of Asia-Pacific
- 9.4.11.1. Introduction
- 9.4.12.2. Driving Factors, Opportunity Analyzed and Key Trends
- 9.4.12.3. Market Size and Forecast, By Technology, 2020 - 2028
- 9.4.12.4. Market Size and Forecast, By Disease Type, 2020 – 2028
- 9.4.12.5. Market Size and Forecast, By End-user, 2020 - 2028
- 9.5. Rest of The World (RoW)
- 9.5.1. Introduction
- 9.5.2. Driving Factors, Opportunity Analyzed and Key Trends
- 9.5.3. Market Size and Forecast, By Technology, 2020 - 2028
- 9.5.4. Market Size and Forecast, By Disease Type, 2020 – 2028
- 9.5.5. Market Size and Forecast, By End-user, 2020 - 2028
- 9.5.6. Market Size and Forecast, By Region, 2020 - 2028
- 9.5.7. South America
- 9.5.7.1. Introduction
- 9.5.7.2. Driving Factors, Opportunity Analyzed and Key Trends
- 9.5.7.3. Market Size and Forecast, By Technology, 2020 - 2028
- 9.5.7.4. Market Size and Forecast, By Disease Type, 2020 – 2028
- 9.5.7.5. Market Size and Forecast, By End-user, 2020 - 2028
- 9.5.8. Middle East & Africa
- 9.5.8.1. Introduction
- 9.5.8.2. Driving Factors, Opportunity Analyzed and Key Trends
- 9.5.8.3. Market Size and Forecast, By Technology, 2020 - 2028
- 9.5.8.4. Market Size and Forecast, By Disease Type, 2020 – 2028
- 9.5.8.5. Market Size and Forecast, By End-user, 2020 - 2028
- Chapter 10. Competitive Landscape
- 10.1. Introduction
- 10.2. Vendor Share Analysis, 2020/Key Players Positioning 2020
- Chapter 11. Company Profiles
- 11.1. Agilent Technologies, Inc
- 11.1.1. Business Overview
- 11.1.2. Financial Analysis
- 11.1.3. Product Portfolio
- 11.1.4. Recent Development and Strategies Adopted
- 11.1.5. SWOT Analysis
- 11.2. QIAGEN N.V.
- 11.2.1. Business Overview
- 11.2.2. Financial Analysis
- 11.2.3. Product Portfolio
- 11.2.4. Recent Development and Strategies Adopted
- 11.2.5. SWOT Analysis
- 11.3. Thermo Fisher Scientific, Inc.
- 11.3.1. Business Overview
- 11.3.2. Financial Analysis
- 11.3.3. Product Portfolio
- 11.3.4. Recent Development and Strategies Adopted
- 11.3.5. SWOT Analysis
- 11.4. F. Hoffmann-La Roche Ltd.
- 11.4.1. Business Overview
- 11.4.2. Financial Analysis
- 11.4.3. Product Portfolio
- 11.4.4. Recent Development and Strategies Adopted
- 11.4.5. SWOT Analysis
- 11.5. ARUP Laboratories
- 11.5.1. Business Overview
- 11.5.2. Financial Analysis
- 11.5.3. Product Portfolio
- 11.5.4. Recent Development and Strategies Adopted
- 11.5.5. SWOT Analysis
- 11.6. Abbott
- 11.6.1. Business Overview
- 11.6.2. Financial Analysis
- 11.6.3. Product Portfolio
- 11.6.4. Recent Development and Strategies Adopted
- 11.6.5. SWOT Analysis
- 11.7. Myriad Genetics, Inc.
- 11.7.1. Business Overview
- 11.7.2. Financial Analysis
- 11.7.3. Product Portfolio
- 11.7.4. Recent Development and Strategies Adopted
- 11.7.5. SWOT Analysis
- 11.8. bioMérieux SA
- 11.8.1. Business Overview
- 11.8.2. Financial Analysis
- 11.8.3. Product Portfolio
- 11.8.4. Recent Development and Strategies Adopted
- 11.8.5. SWOT Analysis
- 11.9. Illumina, Inc.
- 11.9.1. Business Overview
- 11.9.2. Financial Analysis
- 11.9.3. Product Portfolio
- 11.9.4. Recent Development and Strategies Adopted
- 11.9.5. SWOT Analysis
- 11.10. Invivoscribe, Inc.
- 11.10.1. Business Overview
- 11.10.2. Financial Analysis
- 11.10.3. Product Portfolio
- 11.9.4. Recent Development and Strategies Adopted
- 11.9.5. SWOT Analysis
- Chapter 12. Key Takeaways
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook